triptolide has been researched along with Cancer of Ovary in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (4.76) | 29.6817 |
2010's | 13 (61.90) | 24.3611 |
2020's | 7 (33.33) | 2.80 |
Authors | Studies |
---|---|
Blazar, BR; Cuellar, RA; Georg, GI; Gurvich, VJ; Lis, LG; Morgan, ML; Norris, BJ; Patil, S; Schumacher, RJ; Suryanarayanan, R | 1 |
Duan, Y; Gong, K; Guo, Q; He, D; Li, H; Li, L; Liu, F; Ru, D; Wang, L; Zhang, Z | 1 |
Brozovic, A; Dabelić, S; Köhrer, K; Kralj, J; Pernar Kovač, M; Polančec, DS; Wachtmeister, T | 1 |
Chen, Q; Gao, M; Hu, L; Jiang, H; Jiang, Y; Wang, Q; Xie, S; Zhang, H; Zhuang, L | 1 |
Du, J; Fei, F; Li, C; Li, Y; Liu, K; Wang, X; Zhang, S; Zheng, M | 1 |
Hu, H; Huang, G; Tan, B; Tong, Y; Yang, L; Zhu, S | 1 |
Czogalla, B; Fraungruber, P; Heidegger, H; Jeschke, U; Kaltofen, T; Mahner, S; Mayr, D; Preinfalk, V; Schwertler, S; Trillsch, F; Vattai, A; Vilsmaier, T | 1 |
Cheng, J; Le, F; Luo, C; Tan, B; Wu, X; Xu, F; Zhang, X; Zhong, Y; Zuo, Q | 1 |
Chen, C; Duan, Y; Gong, K; Guo, Q; He, D; Li, H; Li, L; Liu, F; Wang, Y; Xu, X | 1 |
Chen, T; Feng, Y; Hu, H; Huang, G; Li, X; Tan, B; Wang, H; Wang, X | 1 |
Liu, Y; Ma, X; Su, S; Wang, R | 1 |
Duan, Y; Gao, P; Huang, C; Li, H; Liu, L; Ru, D; Shen, M; Sun, Y; Xiong, X; Zhang, X | 1 |
Ding, C; Duan, Y; Li, H; Liu, H; Ru, D; Shen, M | 1 |
Cai, YY; Li, AP; Lin, WP; Xu, JY | 1 |
Feng, H; Li, Y; Tang, H; Xu, H | 1 |
Ding, H; Fu, T; Gong, X; Li, JM; Li, QQ; Lu, Y; Ma, Y; Wang, L; Weintraub, M; Wu, J; Wu, S; Zhou, H | 1 |
Geller, M; Ramakrishnan, S; Rivard, C; Saluja, A; Saluja, M; Schnettler, E; Vogel, RI | 1 |
Li, H; Liu, T; Wang, Y | 1 |
Furukawa, Y; Kong, S; Li, H; Moriyama, M; Narahara, H; Takai, N; Tsukamoto, Y; Tsuno, A; Yuge, A | 1 |
Mei, Q; Wang, M; Wang, X; Wang, Y; Wang, Z; Yang, Z; Zhang, X; Zhao, H | 1 |
Nilsson, EE; Skinner, MK; Westfall, SD | 1 |
21 other study(ies) available for triptolide and Cancer of Ovary
Article | Year |
---|---|
Phosphonooxymethyl Prodrug of Triptolide: Synthesis, Physicochemical Characterization, and Efficacy in Human Colon Adenocarcinoma and Ovarian Cancer Xenografts.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Colon; Colonic Neoplasms; Diterpenes; Drug Stability; Epoxy Compounds; Female; HT29 Cells; Humans; Mice; Mice, Nude; Organophosphates; Ovarian Neoplasms; Ovary; Phenanthrenes; Prodrugs; Solubility | 2015 |
Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cisplatin; Diterpenes; Drug Resistance, Neoplasm; Epoxy Compounds; Exosomes; Humans; Liposomes; MicroRNAs; Nanoparticles; Ovarian Neoplasms; Phenanthrenes; Phosphatidylinositol 3-Kinases | 2022 |
Transcriptome analysis of newly established carboplatin-resistant ovarian cancer cell model reveals genes shared by drug resistance and drug-induced EMT.
Topics: Carboplatin; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Humans; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Sirolimus | 2023 |
Triptolide inhibits epithelial ovarian tumor growth by blocking the hedgehog/Gli pathway.
Topics: Cell Line, Tumor; Female; Hedgehog Proteins; Humans; Ovarian Neoplasms; Signal Transduction; Zinc Finger Protein GLI1 | 2023 |
EMT-related protein expression in polyploid giant cancer cells and their daughter cells with different passages after triptolide treatment.
Topics: Antineoplastic Agents, Alkylating; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Diterpenes; Epithelial-Mesenchymal Transition; Epoxy Compounds; Female; Gene Expression Regulation, Neoplastic; Giant Cells; Humans; Neoplasm Invasiveness; Ovarian Neoplasms; Phenanthrenes; Polyploidy | 2019 |
Antitumor activity of triptolide in SKOV3 cells and SKOV3/DDP in vivo and in vitro.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Biomarkers, Tumor; Calcium-Binding Proteins; Cell Proliferation; Diterpenes; Epoxy Compounds; Female; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Matrix Metalloproteinase 2; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Phenanthrenes; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2020 |
Potential of platinum-resensitization by Wnt signaling modulators as treatment approach for epithelial ovarian cancer.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Cadherins; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Movement; Diterpenes; Drug Resistance, Neoplasm; Epoxy Compounds; Female; Heterocyclic Compounds, 3-Ring; Humans; Indoles; Maleimides; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Ovarian Neoplasms; Phenanthrenes; Wnt Signaling Pathway | 2020 |
Triptolide inhibits JAK2/STAT3 signaling and induces lethal autophagy through ROS generation in cisplatin‑resistant SKOV3/DDP ovarian cancer cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Cisplatin; Diterpenes; Drug Resistance, Neoplasm; Epoxy Compounds; Female; Humans; Janus Kinase 2; Mice; Ovarian Neoplasms; Phenanthrenes; Reactive Oxygen Species; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2021 |
Functional Exosome-Mediated Delivery of Triptolide Endowed with Targeting Properties as Chemotherapy Carriers for Ovarian Carcinoma.
Topics: Apoptosis; Diterpenes; Epoxy Compounds; Exosomes; Female; Humans; Ovarian Neoplasms; Phenanthrenes; Tumor Microenvironment | 2021 |
Inhibition effect of triptolide on human epithelial ovarian cancer via adjusting cellular immunity and angiogenesis.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Cell Movement; Cell Proliferation; Diterpenes; Drug Resistance, Neoplasm; Epoxy Compounds; Female; Humans; Immunity, Cellular; Immunosuppressive Agents; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Glandular and Epithelial; Neovascularization, Pathologic; Ovarian Neoplasms; Phenanthrenes; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |
Triptolide antagonized the cisplatin resistance in human ovarian cancer cell line A2780/CP70 via hsa-mir-6751.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cisplatin; Diterpenes; Drug Resistance, Neoplasm; Epoxy Compounds; Female; Gene Expression Regulation, Neoplastic; Hexokinase; Humans; MicroRNAs; Ovarian Neoplasms; Phenanthrenes; Up-Regulation | 2018 |
Co-Delivery of Triptolide and Curcumin for Ovarian Cancer Targeting Therapy via mPEG-DPPE/CaP Nanoparticle.
Topics: Animals; Apoptosis; Calcium Phosphates; Cell Line, Tumor; Curcumin; Diterpenes; Epoxy Compounds; Female; Nanoparticles; Ovarian Neoplasms; Phenanthrenes; Phenyl Ethers; Polyethylene Glycols | 2018 |
The Effect of Triptolide-Loaded Exosomes on the Proliferation and Apoptosis of Human Ovarian Cancer SKOV3 Cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Diterpenes; Drug Delivery Systems; Epoxy Compounds; Exosomes; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Ovary; Phenanthrenes; Rabbits; Toxicity Tests; Xenograft Model Antitumor Assays | 2019 |
Combined effects of curcumin and triptolide on an ovarian cancer cell line.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; Blotting, Western; Cell Proliferation; Curcumin; Diterpenes; Drug Synergism; Epoxy Compounds; Female; HSP27 Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Humans; L-Lactate Dehydrogenase; Membrane Potential, Mitochondrial; Ovarian Neoplasms; Phenanthrenes; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 2013 |
Design, synthesis and structure-activity relationships studies on the D ring of the natural product triptolide.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Diterpenes; Drug Design; Epoxy Compounds; Female; Humans; Male; Models, Molecular; Ovarian Neoplasms; Ovary; Phenanthrenes; Prostate; Prostatic Neoplasms; Structure-Activity Relationship; Tripterygium | 2014 |
Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; bcl-2-Associated X Protein; Caspases; Cell Cycle Checkpoints; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Diterpenes; Epoxy Compounds; Female; Genes, p53; Humans; Mitochondria; Mutation; Ovarian Neoplasms; Phenanthrenes; Proto-Oncogene Proteins c-bcl-2 | 2014 |
Inhibition of epithelial ovarian cancer by Minnelide, a water-soluble pro-drug.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carboplatin; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Cell Survival; Diterpenes; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Electric Impedance; Epoxy Compounds; Female; Humans; Mice; Mice, Nude; Neoplasms, Glandular and Epithelial; Organophosphates; Ovarian Neoplasms; Paclitaxel; Phenanthrenes; Prodrugs; Xenograft Model Antitumor Assays | 2014 |
Enhancement of triptolide-loaded micelles on tumorigenicity inhibition of human ovarian cancer.
Topics: Antineoplastic Agents; Apoptosis; Carcinogenesis; Caspases; Cell Line, Tumor; Cell Movement; Cell Proliferation; Diterpenes; Dose-Response Relationship, Drug; Drug Carriers; Epoxy Compounds; Female; Humans; Micelles; Neoplasm Invasiveness; NF-kappa B; Ovarian Neoplasms; Phenanthrenes; S Phase Cell Cycle Checkpoints; Time Factors | 2016 |
Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells.
Topics: Cell Cycle; Cell Death; Cell Growth Processes; Cell Line, Tumor; Diterpenes; Down-Regulation; Endometrial Neoplasms; Epoxy Compounds; Female; Gene Expression Regulation, Neoplastic; Humans; Oligonucleotide Array Sequence Analysis; Ovarian Neoplasms; Phenanthrenes; Tripterygium | 2010 |
Triptolide inhibits ovarian cancer cell invasion by repression of matrix metalloproteinase 7 and 19 and upregulation of E-cadherin.
Topics: Animals; Antigens, CD; Antineoplastic Agents, Alkylating; Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cystadenocarcinoma, Serous; Diterpenes; Epoxy Compounds; Female; Gene Expression Regulation, Enzymologic; Humans; Matrix Metalloproteinase 7; Matrix Metalloproteinases, Secreted; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Ovarian Neoplasms; Paclitaxel; Phenanthrenes; Promoter Regions, Genetic; Up-Regulation; Xenograft Model Antitumor Assays | 2012 |
Role of triptolide as an adjunct chemotherapy for ovarian cancer.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carboplatin; Cell Line, Tumor; Chemotherapy, Adjuvant; Chromones; Diterpenes; Drug Synergism; Enzyme Inhibitors; Epoxy Compounds; Female; Humans; Mice; Mice, Nude; Morpholines; Ovarian Neoplasms; Phenanthrenes; Phosphoinositide-3 Kinase Inhibitors; Remission Induction; Tripterygium; Tumor Burden | 2008 |